Literature DB >> 3977437

Isolation-perfusion of the liver with 5-fluorouracil.

W F Sindelar.   

Abstract

Isolation-perfusion of the liver was performed in ten pigs using 5-fluorouracil administered in the perfusion circuit at doses of 100, 250, 500, and 1000 mg/kg body weight. Perfusion was performed for 60 minutes at normothermic (37 C) or hyperthermic (41 C) temperatures. One animal died shortly after perfusion. Incomplete isolation of the hepatic vasculature in two animals resulted in significant drug leakage into the systemic circulation with resulting hematologic toxicity. Perfusion with 5-fluorouracil at 1000 mg/kg produced hepatic necrosis. Perfusion with 5-fluorouracil at doses of 100, 250, or 500 mg/kg produced no hepatic toxicity except for transient elevations of hepatic enzymes and resulted in no systemic drug toxicity. Levels of 5-fluorouracil tolerated by the liver in the isolation-perfusion system were more than 1000-fold greater than the maximum drug levels achievable by routine systemic, intra-arterial, or intraperitoneal administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977437      PMCID: PMC1250676          DOI: 10.1097/00000658-198503000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Hepatic tissue tolerance to thio-TEPA administered by the isolation-perfusion technique.

Authors:  J E HEALEY; J L SMITH; L CLARK; J S STEHLIN; E C WHITE
Journal:  J Surg Res       Date:  1961-07       Impact factor: 2.192

2.  Isolated perfusion of the liver with HN2.

Authors:  R K AUSMAN; J B AUST
Journal:  Surg Forum       Date:  1960

3.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

4.  Hepatic hyperthermia by total isolation and regional perfusion in vivo.

Authors:  A W Boddie; L Booker; J D Mullins; C J Buckley; C M McBride
Journal:  J Surg Res       Date:  1979-04       Impact factor: 2.192

5.  Isolation and perfusion of the liver of cancer chemotherapy.

Authors:  R J Mulcare; A Solis; J G Fortner
Journal:  J Surg Res       Date:  1973-08       Impact factor: 2.192

6.  Hyperthermic isolation-perfusion in vivo of the canine liver.

Authors:  J L Skibba; R E Condon
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

7.  Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.

Authors:  E V Sugarbaker; C M McBride
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

8.  Results of eleven years' experience with heated perfusion for melanoma of the extremities.

Authors:  J S Stehlin; B C Giovanella; P D de Ipolyi; R F Anderson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

9.  Chemotherapy of sarcomas of the limbs by regional perfusion.

Authors:  E T Krementz; R D Carter; C M Sutherland; I Hutton
Journal:  Ann Surg       Date:  1977-05       Impact factor: 12.969

10.  Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.

Authors:  B L Hillcoat; P B McCulloch; A T Figueredo; M H Ehsan; J M Rosenfeld
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

View more
  2 in total

1.  Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan.

Authors:  I H Borel Rinkes; M R de Vries; A M Jonker; T J Swaak; C E Hack; P T Nooyen; T Wiggers; A M Eggermont
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  An evaluation of hepatic extraction and clearance of doxorubicin.

Authors:  D A August; N Verma; M A Vaertan; R Shah; D E Brenner
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.